CIDRZ Pharmacists receive scholarships to attend UCT School of Business MDI Program for Health Leaders and Managers

 

_DSC0009Kaala Moomba

Congratulations to Helen Mulenga, Mpande Mwenechanya and Kaala Moomba – CIDRZ Pharmacists – who have received scholarships to attend the University of Cape Town, School of Business week-long Management Development Institute (MDI) Program for Health Leaders and Managers taking place this August!

Photos from left – Helen Bwalya Mulenga B. Pharm, MBA – Head, Pharmaceutical Services Department; Mpande Mukumbwa-Mwenechanya B.Pharm, M. Clinical Pharmacy – Program Manager for Population Effects of Antiretroviral Therapy To Reduce HIV Transmission (PopART); and Kaala Moomba B. Pharm, MPH, HILO – ART Acting Provincial Coordinator Southern Province

The MDI is a highly sought after leadership and management development program that aims to strengthen capabilities of managers in the public healthcare sector. Participants attend an intensive week-long training to hone management skills and then apply what they have learned on solving research-identified service delivery challenges in their home setting over the next 12-months while receiving coaching and mentoring by UCT.

The CIDRZ Team plan to tackle these challenges to local healthcare:

  • Improving adverse drug reaction reporting by health care workers in the CIDRZ-supported health facilities in Lusaka, Southern, Western and Eastern provinces of Zambia. By strengthening clinical and pharmacy staff understanding and creating systems to improve this reporting, more accurate data on adverse drug reactions experienced in Zambia will be realized.
  • Increasing Co-trimoxazole prophylaxis administration to eligible HIV-infected children. Research has indicated that co-trimoxazole prophylaxis to protect against early opportunistic infections is safe, inexpensive and highly-effective in reducing morbidity and mortality among HIV-infected infants, children, and adolescents and thus it is imperative that all eligible children are dispensed the drug (WHO 2013). However, routine pharmaceutical monitoring and evaluation indicates co-trimoxazole administration to eligible children in HIV Integrated Local Ownership facilities (2013-2014 Annual Progress Report) has been less that the targeted 100%.

Mpande says: “I am excited to participate in the Management Development Institute because this program will provide technical skills that will enable us to positively contribute to improving pharmacy practice in Zambia. As a team we will collaborate and use our individual strengths, expertise and resources to analyze and identify major health challenges and formulate effective plans to solve and meet these needs. We will also network and learn from other managers in sub-Saharan Africa dedicated to improving health care in their respective countries.”

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *